More specifically, hypomethylation of CpGs located in the promoter region of OXTR exon 1 and hypermethylation of sites located in OXTR intron 3 have been associated with depression and anxiety disorders in subjects with a history of childhood abuse [114]. Here, OXTR is linked to depressive symptom measurement.